about
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients.Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantationHepatitis C virus recurrence and immunosuppression-free state after liver transplantation.Adult liver transplantation in the congenital absence of inferior vena cava.Ante situm liver resection with inferior vena cava replacement under hypothermic cardiopolmunary bypass for hepatoblastoma: Report of a case and review of the literature.Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial.Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis.Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis.Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results.Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation.The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up.First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion.Surgical antibiotic prophylaxis after renal transplantation: time to reconsider.Higher Retransplantation rate following Extended Right Split-Liver Transplantation - An analysis from the Eurotransplant Liver follow-up Registry.Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients.Is routine hepaticojejunostomy at the time of unplanned surgical bypass required in the era of self-expanding metal stents?Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry.Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.Severe unresolved cholestasis due to unknown aetiology leading to early allograft failure within the first 3 months of liver transplantation.Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: report of a case.A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts.The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy.Donation after Circulatory Death in Paediatric Liver Transplantation: Current Status and Future Perspectives in the Machine Perfusion Era.Glycogen Storage Disease Type Ia and VI Associated With Hepatocellular Carcinoma: Two Case ReportsLong-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis CImpact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort studyEverolimus and Enteric-Coated Mycophenolate Sodium Ab Initio after Liver Transplantation: Midterm ResultsSwitch from Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Kidney TransplantationManagement of Spermatic Cord Liposarcoma in Renal Transplant Recipients: Case ReportHepatocellular carcinoma in children: hepatic resection and liver transplantationUsing a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection?Life-saving vascular access after combined liver and kidney transplantation: A challenging access to the right atriumHow Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the LiteraturePrimary Prophylaxis for Gastrointestinal Bleeding in Children With Biliary Atresia and Portal Hypertension Candidates for Liver Transplantation: A Single-Center ExperienceAggressive prevention and preemptive management of vascular complications after pediatric liver transplantation: A major impact on graft survival and long-term outcomeA national mandatory-split liver policy: A report from the Italian experienceThe COVID-19 outbreak in Italy: Initial implications for organ transplantation programsMaple Syrup Urine Disease and Domino Liver Transplantation: When and How?Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand?
P50
Q34168552-473011FE-D8A4-4F54-814D-DC52E86A07C1Q35640630-56E353F2-0C18-48A1-B3C2-964AA8C85879Q38053172-E68F92E0-F42B-49DC-B37B-B642E2CB28F5Q38567771-E0AA731E-6524-4CC2-8948-05AA0CD7CBE1Q39398847-61F49678-F072-484E-BF76-939F96F89DE0Q39436989-FE29E61F-FE8E-4643-A610-EF906024FD1DQ41705798-710719D4-2FB7-4BA9-AE34-D29A752A7707Q41980165-D7C78105-0CB2-4829-B2F0-83EF1D81A05BQ43037553-B815135E-5075-45F8-B0E5-8BBEE001E565Q43037581-D6E72638-CE9A-4BC7-A8A8-CB2958B6C822Q43037604-28413979-4491-444D-8E80-656FCD288729Q44492999-34270635-8354-4C2E-9A02-18D8B077AB7FQ47347380-350E9B7D-F670-47F9-BB7E-C7D769759287Q48352186-D86B9527-2B58-4778-89F3-6E93D4200015Q49850094-45039203-3ABA-4E12-A1CD-D8ADC32AE09FQ50059454-4EA7CA60-A05F-41A2-B45B-A5EEBF7092E1Q50880142-7D9E0220-0D36-45E7-ACA4-B0492997748EQ51744352-84367A41-49AD-40D9-81F2-E2FFAF706C79Q51822089-3C7B4936-F2FB-4F92-A01C-CE1DE0738226Q52809394-FDC756FC-F9E6-4882-AFA7-03C7297C5FC0Q53092955-B484BCCF-20A4-43D2-8947-F604B06B5439Q53196471-16A304BC-A75D-4CE4-A147-B41066C95F55Q55033985-00E993AF-2BC0-40C5-A09A-1BA15EC38F70Q55260952-40187E33-31E0-4749-9DCF-3006670D3927Q57791738-FBDE7A28-D279-4A18-BA68-C6B399D67EB3Q57791759-D0806959-78D0-4C03-B9CA-E4325E937BF8Q57792402-D3FDAC93-3A1D-4D89-B602-F61893878100Q57792492-77573976-0283-4809-98E3-E18AD8CD1683Q57792530-78E9ACF4-78E2-4C04-A518-6A64D77A7DE9Q57792542-DB0F16E0-5500-43BA-91F8-00565E3FCACAQ58555478-089AA103-9944-46B8-A418-7BE9520CB479Q89641610-C8BF9A90-4128-4AF9-AE5B-146AD7F49509Q90875752-CC2AD506-500F-45AF-963B-6734BF8D420FQ91094318-9FE0C402-FE58-412E-9A10-C21A5ECADEB0Q91097635-999464BE-74BD-4286-89DD-334E7F251870Q91255991-D8C62964-36EB-4D51-8EEC-DB6CD227A375Q91480628-93ADF113-6611-4E8C-8A4F-DED4C962C4DAQ91535384-446B59EF-6ED4-488F-BE8E-01C8028D0039Q91640040-B6DAC9CA-6924-4ED9-99CA-31554CD02939Q92350047-5575459C-55EE-41A2-98A2-F3BF0D1C3342
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roberta Angelico
@ast
Roberta Angelico
@en
Roberta Angelico
@es
Roberta Angelico
@nl
type
label
Roberta Angelico
@ast
Roberta Angelico
@en
Roberta Angelico
@es
Roberta Angelico
@nl
prefLabel
Roberta Angelico
@ast
Roberta Angelico
@en
Roberta Angelico
@es
Roberta Angelico
@nl
P106
P1153
36061069200
P21
P31
P496
0000-0002-3439-7750